DK478186A - Praeparat indeholdende et salt af metoprolol og med kontrolleret afgivelse af dette salt - Google Patents
Praeparat indeholdende et salt af metoprolol og med kontrolleret afgivelse af dette salt Download PDFInfo
- Publication number
- DK478186A DK478186A DK478186A DK478186A DK478186A DK 478186 A DK478186 A DK 478186A DK 478186 A DK478186 A DK 478186A DK 478186 A DK478186 A DK 478186A DK 478186 A DK478186 A DK 478186A
- Authority
- DK
- Denmark
- Prior art keywords
- salt
- metoprolol
- preparation containing
- controlled delivery
- beads
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8504721A SE455836B (sv) | 1985-10-11 | 1985-10-11 | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
SE8504721 | 1985-10-11 |
Publications (4)
Publication Number | Publication Date |
---|---|
DK478186D0 DK478186D0 (da) | 1986-10-07 |
DK478186A true DK478186A (da) | 1987-04-12 |
DK165939B DK165939B (da) | 1993-02-15 |
DK165939C DK165939C (da) | 1993-07-05 |
Family
ID=20361706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK478186A DK165939C (da) | 1985-10-11 | 1986-10-07 | Metropololpraeparat med styret, kontinuerlig afgivelse af det aktive stof, farmaceutisk praeparat indeholdende samme og fremgangsmaade til fremstilling af metropololpraeparatet samt anvendelse af metropololpraeparatet til fremstilling af et farmaceutisk praeparat til behandling af kardiovaskulaere lidelser |
Country Status (33)
Country | Link |
---|---|
US (1) | US4957745A (da) |
EP (1) | EP0220143B1 (da) |
JP (1) | JPH0759506B2 (da) |
KR (1) | KR940000100B1 (da) |
CN (1) | CN1023293C (da) |
AT (1) | ATE65391T1 (da) |
AU (1) | AU588630B2 (da) |
CY (1) | CY1616A (da) |
DD (1) | DD259789A5 (da) |
DE (2) | DE220143T1 (da) |
DK (1) | DK165939C (da) |
DZ (1) | DZ994A1 (da) |
ES (1) | ES2003863B3 (da) |
FI (1) | FI88579C (da) |
GB (1) | GB2181348B (da) |
GR (2) | GR890300059T1 (da) |
HK (1) | HK101791A (da) |
HU (1) | HU197839B (da) |
IE (1) | IE59053B1 (da) |
IS (1) | IS1529B (da) |
LT (2) | LT3951B (da) |
LV (3) | LV10913B (da) |
NO (1) | NO172276C (da) |
NZ (1) | NZ217696A (da) |
PH (1) | PH22277A (da) |
PL (1) | PL261802A1 (da) |
PT (1) | PT83509B (da) |
RU (1) | RU2072840C1 (da) |
SE (1) | SE455836B (da) |
SG (1) | SG95291G (da) |
SU (1) | SU1760969A3 (da) |
UA (2) | UA26211A (da) |
ZA (1) | ZA869860B (da) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8703881D0 (sv) * | 1987-10-08 | 1987-10-08 | Haessle Ab | New pharmaceutical preparation |
US4892739A (en) * | 1988-04-25 | 1990-01-09 | Ciba-Geigy Corporation | Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties |
US5268182A (en) * | 1988-06-24 | 1993-12-07 | Abbott Laboratories | Sustained-release drug dosage units of terazosin |
US5612059A (en) * | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
US5084287A (en) * | 1990-03-15 | 1992-01-28 | Warner-Lambert Company | Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat |
EP0542926B1 (en) * | 1990-08-07 | 1995-02-15 | Pfizer Inc. | Use of interfacially-polymerized membranes in delivery devices |
DK0576617T3 (da) * | 1991-03-18 | 1996-12-30 | Sepracor Inc | Præparat og fremgangsmåde indeholdende optisk rent (S) metoprolol |
DK0585355T3 (da) * | 1991-05-20 | 1995-06-06 | Tanabe Seiyaku Co | Flerlagspræparat med reguleret frigivelse |
IT1252185B (it) * | 1991-12-11 | 1995-06-05 | Therapicon Srl | Preparazioni farmaceutiche a liberazione programmata |
US7740881B1 (en) | 1993-07-01 | 2010-06-22 | Purdue Pharma Lp | Method of treating humans with opioid formulations having extended controlled release |
US5399358A (en) * | 1993-11-12 | 1995-03-21 | Edward Mendell Co., Inc. | Sustained release formulations for 24 hour release of metroprolol |
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
SE9702338D0 (sv) * | 1997-06-18 | 1997-06-18 | Astra Ab | An analytical method and industrial process including the same |
SE9802537D0 (sv) * | 1998-07-13 | 1998-07-13 | Astra Ab | Method for controlling a coating process |
US8236352B2 (en) | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
WO2000018374A1 (en) * | 1998-10-01 | 2000-04-06 | Elan Pharma International, Ltd. | Controlled release nanoparticulate compositions |
US8293277B2 (en) | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
DE19848651C1 (de) * | 1998-10-22 | 2000-01-27 | Porsche Ag | Tülle für ein Kabelbündel |
MXPA01007463A (es) | 1999-01-29 | 2002-06-04 | Losan Pharma Gmbh | Composiciones farmaceuticas. |
FR2802424B1 (fr) * | 1999-12-17 | 2002-02-15 | Adir | Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale |
US7198795B2 (en) | 2000-09-21 | 2007-04-03 | Elan Pharma International Ltd. | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions |
GB0025208D0 (en) | 2000-10-13 | 2000-11-29 | Euro Celtique Sa | Delayed release pharmaceutical formulations |
SE0100200D0 (sv) * | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
US20040105886A1 (en) * | 2001-02-16 | 2004-06-03 | Chih-Ming Chen | Divalproex sodium tablets |
US6610326B2 (en) * | 2001-02-16 | 2003-08-26 | Andrx Corporation | Divalproex sodium tablets |
SE0100824D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method III to obtain microparticles |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
BR0206441A (pt) * | 2001-12-19 | 2003-12-30 | Astrazeneca Ab | Composição de revestimento de pelìcula, revestimento de pelìcula cobrindo um núcleo farmacêutico, formulação farmacêutica de liberação modificada, e, processos para preparar uma composição de revestimento de pelìcula, um revestimento de pelìcula e uma formulação |
CA2475092C (en) | 2002-02-04 | 2012-05-01 | Christian F. Wertz | Nanoparticulate compositions having lysozyme as a surface stabilizer |
AU2003230805A1 (en) * | 2002-04-05 | 2003-10-27 | Penwest Pharmaceuticals Co. | Sustained release metoprolol formulations |
SE0201110D0 (sv) * | 2002-04-12 | 2002-04-12 | Astrazeneca Ab | New film coating |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
US7217300B2 (en) | 2003-06-27 | 2007-05-15 | Delphi Technologies, Inc. | Method and apparatus for gasketing a fuel cell |
US7314640B2 (en) * | 2003-07-11 | 2008-01-01 | Mongkol Sriwongjanya | Formulation and process for drug loaded cores |
US20050032879A1 (en) * | 2003-08-07 | 2005-02-10 | Temple Okarter | Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases |
EP1722758A1 (en) * | 2004-02-11 | 2006-11-22 | Athpharma Limited | Chronotherapeutic compositions and methods of their use |
US20060105044A1 (en) | 2004-05-20 | 2006-05-18 | Singh Bramah N | Sustained release formulations of sotalol |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
NZ589750A (en) | 2004-10-21 | 2012-07-27 | Aptalis Pharmatech Inc | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
EP1898886B1 (en) | 2005-07-01 | 2019-09-04 | Rubicon Research Pvt Ltd. | Novel sustained release dosage form |
US20070009589A1 (en) * | 2005-07-07 | 2007-01-11 | Kandarapu Raghupathi | Extended release compositions |
WO2007010501A2 (en) * | 2005-07-22 | 2007-01-25 | Ranbaxy Laboratories Limited | A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor |
US20070053983A1 (en) * | 2005-09-06 | 2007-03-08 | Girish Jain | Extended release compositions of metoprolol succinate |
US20070092573A1 (en) * | 2005-10-24 | 2007-04-26 | Laxminarayan Joshi | Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
DE102005060393A1 (de) * | 2005-12-16 | 2007-06-21 | Add Advanced Drug Delivery Technologies Ltd. | Orales Präparat mit kontrollierter Freisetzung |
US8691272B2 (en) * | 2005-12-30 | 2014-04-08 | Intelgenx Corp. | Multilayer tablet |
PL1842534T3 (pl) * | 2006-02-24 | 2012-05-31 | Teva Pharma | Tabletki bursztynianu metoprololu o przedłużonym uwalnianiu oraz sposoby ich wytwarzania |
US20090068260A1 (en) * | 2006-02-24 | 2009-03-12 | Tomer Gold | Beta-1-selective adrenoceptor blocking agent compositions and methods for their preparation |
BRPI0714586A2 (pt) * | 2006-07-28 | 2013-05-07 | Farmaprojects S A | formulaÇço farmacÊutica de liberaÇço prolongada de metropolol e processo para a sua preparaÇço |
US20080107726A1 (en) * | 2006-11-01 | 2008-05-08 | Pramod Kharwade | Compositions comprising beta-adrenergic receptor antagonists and diuretics |
US20080187579A1 (en) * | 2007-02-01 | 2008-08-07 | Pavan Bhat | Extended-release dosage form |
WO2008103245A2 (en) * | 2007-02-23 | 2008-08-28 | Glatt Air Techniques, Inc. | Method of determining the weight of the coating to be applied to form a controlled release dosage form |
PL2255791T3 (pl) * | 2009-04-03 | 2012-05-31 | Zakl Farmaceutyczne Polpharma Sa | Kompozycja farmaceutyczna o przedłużonym uwalnianiu zawierająca bursztynian metoprololu |
JP5309262B2 (ja) | 2009-12-02 | 2013-10-09 | アプタリス ファーマ リミテッド | フェキソフェナジン・マイクロカプセル及びそれを含む組成物 |
US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
CN102670539A (zh) * | 2011-03-14 | 2012-09-19 | 北京天衡药物研究院 | 琥珀酸美托洛尔渗透泵控释片 |
WO2014124700A1 (en) | 2013-02-13 | 2014-08-21 | Evonik Industries Ag | Multiparticulate pharmaceutical composition comprising a multitude of two kinds of pellets |
CA2904155A1 (en) * | 2013-03-15 | 2014-09-18 | David Barnes | Compositions and methods for administration to subjects with dysphagia |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH532038A (de) * | 1970-05-25 | 1972-12-31 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Cycloheptenderivaten |
US3951821A (en) * | 1972-07-14 | 1976-04-20 | The Dow Chemical Company | Disintegrating agent for tablets |
US4036227A (en) | 1973-04-25 | 1977-07-19 | Alza Corporation | Osmotic releasing device having a plurality of release rate patterns |
US4123382A (en) * | 1973-05-25 | 1978-10-31 | Merck & Co., Inc. | Method of microencapsulation |
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
US4291016A (en) * | 1976-07-27 | 1981-09-22 | Sandoz Ltd. | Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate |
GB1542414A (en) * | 1976-08-19 | 1979-03-21 | Standard Telephones Cables Ltd | Arrangements for the controlled release of biologically active materials |
DE2642032A1 (de) * | 1976-09-18 | 1978-03-30 | Merck Patent Gmbh | Siliciumdioxidhaltige zubereitungen und verfahren zu ihrer herstellung |
GB1576376A (en) * | 1977-03-30 | 1980-10-08 | Benzon As Alfred | Multiple-unit drug dose |
US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
SE426548B (sv) * | 1978-12-05 | 1983-01-31 | Haessle Ab | Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer |
US4309406A (en) * | 1979-07-10 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4309404A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
CH655658B (da) * | 1980-09-18 | 1986-05-15 | ||
US4439195A (en) * | 1980-10-14 | 1984-03-27 | Alza Corporation | Theophylline therapy |
US4326525A (en) * | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
IT1144911B (it) * | 1981-03-19 | 1986-10-29 | Pharmatec Spa | Composizione farmaceutica a rilascio controllato contenente ibuprofen |
GB2098867B (en) * | 1981-05-21 | 1984-10-24 | Wyeth John & Brother Ltd | Sustained release pharmaceutical composition |
US4484921A (en) * | 1982-02-01 | 1984-11-27 | Alza Corporation | Theophylline therapy utilizing osmotic delivery |
US4449983A (en) * | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
US4642233A (en) * | 1982-03-22 | 1987-02-10 | Alza Corporation | Gastrointestinal drug delivery system comprising a hydrogel reservoir containing a plurality of tiny pills |
US4649043A (en) * | 1982-03-22 | 1987-03-10 | Alza Corporation | Drug delivery system for delivering a plurality of tiny pills in the gastrointestinal tract |
US4434153A (en) * | 1982-03-22 | 1984-02-28 | Alza Corporation | Drug delivery system comprising a reservoir containing a plurality of tiny pills |
US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
ZA836627B (en) * | 1982-10-08 | 1984-05-30 | Verex Lab | Constant release rate solid oral dosage formulation of pharmaceutical compounds having a high degree of water solubility |
US4681583A (en) * | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
US4578075A (en) * | 1982-12-20 | 1986-03-25 | Alza Corporation | Delivery system housing a plurality of delivery devices |
PH18946A (en) * | 1983-04-21 | 1985-11-14 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
AU581177B2 (en) * | 1983-05-31 | 1989-02-16 | Choong-Gook Jang | Dry direct compression compositions for controlled release dosage forms |
GB2146531B (en) * | 1983-09-15 | 1987-04-29 | Stc Plc | Controlled release system |
SE457505B (sv) | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
JPH0759499B2 (ja) * | 1984-02-10 | 1995-06-28 | ベンツォン ファーマ エイ/エス | 拡散被覆された複合単位服用剤 |
IT1206166B (it) * | 1984-07-26 | 1989-04-14 | Sigma Tau Ind Farmaceuti | Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione |
GB2159715B (en) * | 1984-06-04 | 1988-05-05 | Sterwin Ag | Pharmaceutical composition in sustained release unit dose form and process for its preparation |
NL8500724A (nl) * | 1985-03-13 | 1986-10-01 | Univ Groningen | Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan. |
-
1985
- 1985-10-11 SE SE8504721A patent/SE455836B/sv not_active IP Right Cessation
-
1986
- 1986-09-09 ZA ZA869860A patent/ZA869860B/xx unknown
- 1986-09-18 IE IE249286A patent/IE59053B1/en not_active IP Right Cessation
- 1986-09-25 PH PH34289A patent/PH22277A/en unknown
- 1986-09-25 GB GB8623048A patent/GB2181348B/en not_active Expired
- 1986-09-26 AU AU63171/86A patent/AU588630B2/en not_active Expired
- 1986-09-26 NZ NZ217696A patent/NZ217696A/xx unknown
- 1986-10-02 AT AT86850330T patent/ATE65391T1/de not_active IP Right Cessation
- 1986-10-02 DE DE198686850330T patent/DE220143T1/de active Pending
- 1986-10-02 DE DE8686850330T patent/DE3680450D1/de not_active Expired - Lifetime
- 1986-10-02 ES ES86850330T patent/ES2003863B3/es not_active Expired - Lifetime
- 1986-10-02 EP EP86850330A patent/EP0220143B1/en not_active Expired - Lifetime
- 1986-10-07 NO NO863997A patent/NO172276C/no unknown
- 1986-10-07 DK DK478186A patent/DK165939C/da not_active IP Right Cessation
- 1986-10-08 DZ DZ860208A patent/DZ994A1/fr active
- 1986-10-09 JP JP61239424A patent/JPH0759506B2/ja not_active Expired - Lifetime
- 1986-10-09 PT PT83509A patent/PT83509B/pt unknown
- 1986-10-10 UA UA4028342A patent/UA26211A/uk unknown
- 1986-10-10 IS IS3151A patent/IS1529B/is unknown
- 1986-10-10 SU SU864028342A patent/SU1760969A3/ru active
- 1986-10-10 PL PL1986261802A patent/PL261802A1/xx unknown
- 1986-10-10 FI FI864108A patent/FI88579C/fi not_active IP Right Cessation
- 1986-10-10 KR KR1019860008481A patent/KR940000100B1/ko not_active IP Right Cessation
- 1986-10-10 HU HU864249A patent/HU197839B/hu unknown
- 1986-10-10 DD DD86295170A patent/DD259789A5/de unknown
- 1986-10-11 CN CN86106588A patent/CN1023293C/zh not_active Expired - Lifetime
-
1989
- 1989-02-14 US US07/310,489 patent/US4957745A/en not_active Expired - Lifetime
- 1989-06-22 GR GR89300059T patent/GR890300059T1/el unknown
-
1991
- 1991-08-19 GR GR91401214T patent/GR3002571T3/el unknown
- 1991-09-10 RU SU915001493A patent/RU2072840C1/ru active
- 1991-09-10 UA UA5001493A patent/UA39162C2/uk unknown
- 1991-11-08 SG SG952/91A patent/SG95291G/en unknown
- 1991-12-12 HK HK1017/91A patent/HK101791A/xx not_active IP Right Cessation
-
1992
- 1992-07-10 CY CY1616A patent/CY1616A/xx unknown
-
1993
- 1993-06-28 LV LVP-93-685A patent/LV10913B/en unknown
- 1993-06-30 LV LV930884A patent/LV10914A/xx unknown
- 1993-12-28 LT LTIP1679A patent/LT3951B/lt not_active IP Right Cessation
- 1993-12-28 LT LTIP1680A patent/LTIP1680A/xx not_active Application Discontinuation
-
1996
- 1996-07-17 LV LV960258A patent/LV5751B4/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK478186D0 (da) | Praeparat indeholdende et salt af metoprolol og med kontrolleret afgivelse af dette salt | |
EP0042089A3 (en) | 4-heterocylic substituted dihydropyridines, processes for preparing them, their therapeutical use and their preparation | |
DE2861791D1 (en) | Polyamide based membrane for hemofiltration, method for its preparation, and its use | |
DK153948C (da) | Analogifremgangsmaade til fremstilling af vandoploeselige associationsprodukter af (+)-katekin med en aminosyre og eventuelt tillige en anden syre | |
ES8404693A1 (es) | Procedimiento de preparacion de nuevos amino-14 esteroides. | |
DK163732C (da) | N-oe2-oeoe5-(aminomethyl)-2-fyranylaamethylthioaa-ethylaa-2-nitro-1,1-ethen-diaminderivater, fremgangsmaade til deres fremstilling og anvendelse af derivaterne til fremstilling af laegemidler | |
DE3379467D1 (en) | L-glutamic acid oxidase, its production, and its use | |
ZA838708B (en) | Apparatus and method for the production of concentrated,enriched protein,in particular of animal blood and other natural base materials | |
LTIP865A (en) | Acrylic acid derivatives, processes for preparing thereof and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |